No matter what the MOS, Bavi will show extended survival in many of these patients and it is totally safe.
That is why I say, if they only match MOS, the FDA will love it...BECAUSE there will be many survivors whose Cancer is gone or will soon be gone and never to return.
The FDA will need to re-evaluate MOS as the key and start looking at long term Survival per centages, especially with immunotherapy drugs.
Is 19 mnths good?